Design Therapeutics DSGN
NASDAQ DSGN
$10.60 -0.13 (-1.21%)
As of: Oct 22, 2026 · 9:30 AM EDT

Design Therapeutics (DSGN) Long-Term Debt Issuances (2020)

Updated

Analysis

Design Therapeutics (DSGN) Long-Term Debt Issuances (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,149.64 Bn 1,118.23 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 626.55 Bn 545.08 Bn 17.26 Bn -
3 AbbVie 498.79 Bn 471.91 Bn 12.70 Bn -
4 Merck 371.66 Bn 326.04 Bn 12.21 Bn -
5 Novartis Ag 299.96 Bn 263.95 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 263.22 Bn 236.91 Bn 12.86 Bn -
7 Amgen 237.03 Bn 192.43 Bn 7.24 Bn -
8 Gilead Sciences 191.20 Bn 165.40 Bn 6.22 Bn -
9 Pfizer 170.83 Bn 117.47 Bn 10.94 Bn -
10 Design Therapeutics 662.56 Mn -193.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 200,000.00
API Access

Design Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=DSGN&period=max&api_key=YOUR_API_KEY